课题基金 / 基金详情

Targeting TAZ and YAP: a new approach to anti-fibrotic therapy in the kidney

Targeting TAZ and YAP: a new approach to anti-fibrotic therapy in the kidney
靶向 TAZ 和 YAP:肾脏抗纤维化治疗的新方法
批准号:
321835
负责人:
Yuen Darren A
金额:
$52.77万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-03-01 至 2020-03-01

项目摘要

项目成果

Yuen Darren A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Scarring is a major cause of chronic organ failure, accounting for up to 50% of all deaths in the developed world. In the kidney, scarring is the final common pathway of damage activated by nearly all forms of chronic kidney disease. If left unchecked, ki
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
YAP and TAZ: novel regulators of collapsing glomerulopathy
  • 批准号:
    478296
  • 项目类别:
    Operating Grants
  • 资助金额:
    $63.81万
  • 财政年份:
    2023
  • 负责人:
    Yuen Darren A
  • 依托单位:
YAP and TAZ: novel regulators of collapsing glomerulopathy
  • 批准号:
    477295
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Yuen Darren A
  • 依托单位:
Canada Research Chair - Tier 2
  • 批准号:
    459666
  • 项目类别:
  • 资助金额:
    $43.71万
  • 财政年份:
    2021
  • 负责人:
    Yuen Darren A
  • 依托单位:
Using "enhanced ultrasound" to help select the best kidneys for transplantation
  • 批准号:
    396162
  • 项目类别:
    Operating Grants
  • 资助金额:
    $35.82万
  • 财政年份:
    2018
  • 负责人:
    Yuen Darren A
  • 依托单位:
海外基金